Correlational studies on insulin resistance and leptin gene polymorphisms in peritoneal dialysis patients

被引:0
|
作者
Cao, Liou [1 ]
Mou, Shan [1 ]
Fang, Wei [1 ]
Qi, Chaojun [1 ]
Chang, Xinbei [1 ]
Gu, Leyi [1 ]
Qian, Jiaqi [1 ]
Ni, Zhaohui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Ctr Peritoneal Dialysis Res, Mol Cell Lab Kidney Dis, Dept Nephrol,Renji Hosp,Sch Med, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
Insulin resistance; Leptin; Peritoneal dialysis; Polymorphisms; OBESE GENE; RECEPTOR GENE; OB GENE; PROMOTER; FAMILY; WOMEN;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s): The aim of the study was to investigate the relationship between insulin resistance (IR) and leptin (LEP) gene polymorphisms in peritoneal dialysis (PD) patients. Materials and Methods: From July 1, 2011 to August 1, 2011, patients who received chronic PD were chosen and divided into three groups (DM, high HOMR-IR, and low HOMR-IR). Two PCR products of LEP were sequenced and aligned and the distribution of polymorphisms was analyzed using chi(2) analysis. In addition, serum leptin level, PD conditions, and biochemical parameters according to different genotype of G-2548A and A19G were statistically analyzed (P-value<0.05). The relationship between LEP gene polymorphisms and prognosis was explored. Results: Totally 157 patients with average age of 55 +/- 15 years old were chosen. Distribution of genotype frequencies was complied with Hardy-Weinberg equilibrium. Leptin level and BMI (body mass index) of the GG genotype of G-2548A were higher than that of GA or AA. The fasting glucose, cholesterol, etc. of AA genotype were lower, and the nPCR was higher than the two other genotypes. Serum leptin level and BMI of AA genotype of A19G was higher than GA and GG genotypes; meanwhile, fasting blood glucose of that genotypes was the highest. In addition, survival rate of AA group of A19G was very low. Conclusion: The G-2548A and A19G polymorphisms were correlated with serum leptin level and IR. Leptin A19G polymorphism may be prognostic for PD patients. This study may facilitate early intervention for IR in PD patients.
引用
收藏
页码:878 / 886
页数:9
相关论文
共 50 条
  • [31] Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer
    Mustafa Akker
    Sibel Güldiken
    Tammam Sipahi
    Orkide Palabıyık
    Ayhan Tosunoğlu
    Özlem Çelik
    Nermin Tunçbilek
    Atakan Sezer
    Necdet Süt
    Molecular Biology Reports, 2014, 41 : 3541 - 3547
  • [32] Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer
    Akker, Mustafa
    Guldiken, Sibel
    Sipahi, Tammam
    Palabiyik, Orkide
    Tosunoglu, Ayhan
    Celik, Ozlem
    Tuncbilek, Nermin
    Sezer, Atakan
    Sut, Necdet
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (05) : 3541 - 3547
  • [33] Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients
    El-Shal, Amal S.
    Pasha, Heba F.
    Rashad, Nearmeen M.
    GENE, 2013, 515 (01) : 233 - 238
  • [34] RESISTANCE TO STIMULATING ERYTHROPOIESIS IN PATIENTS ON PERITONEAL DIALYSIS
    Cabana Carcasi, Mara Lisbet L.
    Fernandez Ferreiro, Anxo
    Fidalgo Diaz, Manuel
    Becerra Mosquera, Vanesa
    Alonso Valente, Rafael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 436 - 436
  • [35] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Doh, Fa Mee
    Chang, Tae-Ik
    Koo, Hyang Mo
    Lee, Mi Jung
    Shin, Dong Ho
    Kim, Chan Ho
    Ko, Kwang Il
    Oh, Hyung Jung
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Han, Dae-Suk
    Han, Seung Hyeok
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (06) : 501 - 509
  • [36] The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis
    Fa Mee Doh
    Tae-Ik Chang
    Hyang Mo Koo
    Mi Jung Lee
    Dong Ho Shin
    Chan Ho Kim
    Kwang Il Ko
    Hyung Jung Oh
    Tae-Hyun Yoo
    Shin-Wook Kang
    Dae-Suk Han
    Seung Hyeok Han
    Cardiovascular Drugs and Therapy, 2012, 26 : 501 - 509
  • [37] Changes of serum leptin levels and the influential factors in peritoneal dialysis patients
    晏焕青
    China Medical Abstracts(Internal Medicine), 2014, 31 (01) : 48 - 48
  • [38] Human recombinant erythropoietin (EPO) corrects insulin resistance and hyperlipidemia in patients on peritoneal dialysis (PD).
    Mak, RHK
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1208 - A1208
  • [39] The effects of serum leptin levels on thrombocyte aggregation in peritoneal dialysis patients
    Bakirdogen, Serkan
    Eren, Necmi
    Bek, Sibel Gokcay
    Mehtap, Ozgur
    Cekmen, Mustafa Baki
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (06) : 1464 - 1467
  • [40] THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON INSULIN RESISTANCE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Chang, Tae Ik
    Shin, Dong Ho
    Oh, Hyung Jung
    Kang, Shin-Wook
    Han, Dae-Suk
    Yoo, Tae-Hyun
    Han, Seung Hyeok
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 471 - 472